McKesson Corporation (MCK) Stock Score, Valuation & Financial Research
McKesson Corporation is in the Healthcare sector and Medical - Distribution industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 56/100.
Quick answer for MCK
McKesson Corporation currently has a Wall Street Score of 56/100. The stored market price is $896.28. Its financial score is 42/100. Its valuation score is 75/100. These figures are a research snapshot, not a buy or sell recommendation.
What McKesson Corporation does
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally,
MCK financial snapshot
- Wall Street Score:
- 56/100
- Current price:
- $896.28
- Market capitalization:
- $104.93B
- Revenue:
- $403.43B
- Net income:
- $4.76B
- Free cash flow:
- $5.72B
- Cash:
- $3.98B
- Total debt:
- $8.61B
- EPS:
- 38.55
- P/E ratio:
- 23.2x
- Financial score:
- 42/100
- Valuation score:
- 75/100
- Revenue score:
- 37/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $5.72B, showing positive cash generation.
- The balance sheet shows $3.98B of cash versus $8.61B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 75/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 42/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MCK
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.